DOT Direct Observation Requirements Go Into Effect on August 31st

On July 30, 2009, the Department of Transportation issued a final rule reinstating the direct observation drug testing procedures recently approved by the U.S. Court of Appeals for the District of Columbia. The final rule, which goes into effect on August 31, 2009, requires that all return-to-duty and follow-up tests be conducted in a manner that permits the direct observation of specimen collection to prevent the use of prosthetic or other cheating devices.

D.C. Circuit Upholds "Direct Observation" Requirements for USDOT Return to Duty and Follow Up Testing

In a decision released May 15, 2009, the U.S. Court of Appeals for the District of Columbia upheld a Department of Transportation (DOT) regulation that requires employees who are returning to safety-sensitive duties after having completed a drug treatment program due to failing or refusing to take a drug test, to submit to return to duty and follow up testing under "direct observation" conditions. This decision and the regulation it upholds applies to employers in the aviation, rail, motor carrier, mass transit, maritime and pipeline industries that are subject to the DOT drug-testing regime. Under the regulation’s "direct observation" procedures, the employer must require a same-gender observer to “watch the urine go from the employee’s body into the collection container.” To comply, employees must raise their shirts above the waist and lower their clothing so as to expose their genitals and allow the observers to verify the absence of any devices that would permit the employee to cheat the test. 

Previously, the employer had the option to require direct observation, but this was not mandatory under the former regulation. Concerned that employers were reticent to require direct observation and in light of the rise in commercially available devices, such as the "Whizzinator," that enable people to cheat on their drug tests, the DOT promulgated this new regulation requiring direct observation for all return to work and follow up tests conducted under the DOT's auspices as of November 1, 2008.

Several transportation industry unions and the BNSF Railway Company challenged the new regulation, and the D.C. Circuit issued a stay of the direct observation requirement back on November 12, 2008. Impressed with evidence that demonstrated the growth of an entire industry focused on circumventing drug tests, coupled with evidence that employees that previously had tested positive or refused drug testing presented an elevated risk of cheating, the court in its May 15th decision found that the DOT had justified the direct observation requirement.  From a constitutional standpoint, the court also found that "given the combination of the vital importance of transportation safety, the employees’ participation in a pervasively regulated industry, their prior violations of the drug regulations, and the ease of obtaining cheating devices capable of defeating standard testing procedures, ... the challenged regulations [are]facially valid under the Fourth Amendment."

At the conclusion of its decision, the court emphasized that, because this case presented only a facial challenge to the direct observation requirement, the court considered only “whether the tests contemplated by the regulations can ever be conducted.” The court expressed no view on either the merits of "any as-applied challenge to this rule" or the constitutionality of any other rule. As such, employers that will be governed by the direct observation requirement would be wise to ensure that, given the intrusion into privacy necessarily associated with the requirement, all persons or entities that conduct such tests on their behalf are properly trained in the DOT regulations and procedures and that they conduct such tests consistent with those regulations and procedures in a professional manner that preserves as best as possible the dignity of the testing subject.

Court Stays DOT's Mandatory Direct Observation for Return-to-Duty and Follow-up Testing

The U.S. Department of Transportation’s (DOT’s) previously announced mandatory direct observation of specimen collection for return-to-duty and follow-up controlled substances test (see my October 28th post) has been stayed. The United States Court of Appeals for the District of Columbia Circuit has issued an administrative stay, which temporarily delays implementation of DOT’s direct observation requirement. As a result of the court-ordered stay, DOT has announced that direct observation by DOT-regulated employers for these two types of tests will remain optional and at the employer’s discretion. We will keep you posted on further developments.

 

Employers Subject to the U.S. Department of Transportation's Substance Abuse Testing Requirements Must Now Conduct Direct Observation for Return to Duty and Follow-up Testing

Beginning November 1, 2008, employers covered by the United States Department of Transportation’s controlled-substance testing regulations must conduct direct observation collection for “return to duty” and “follow-up” controlled substance tests. These regulations apply to employers governed by the Federal Highway Administration (such as private motor carriers), the Federal Railroad Administration (which regulates railroad operators), the Federal Aviation Administration (which regulates airlines and related industries), the Federal Transit Authority (which regulates companies doing business with mass transit providers), and the Research and Special Programs Administration (which regulates pipeline industries).

Part of the DOT’s rationale for requiring direct observation for these two types of tests is the fact that the individuals subject to these two tests have already tested positive or refused to submit to testing in violation of DOT’s controlled-substance testing requirements. The DOT believes the individuals in these categories have a greater than average likelihood of using illegal drugs in the future and, consequently, higher than average motivation to cheat on a test. In addition, the Department has studied the dramatic increase in available cheating products on the market, which are solely designed to help illegal drug users defeat drug tests. Some of these products that are now sold to help employees avoid detection include prosthetic devices that look like real human anatomy, even color matched.

The DOT is implementing this observation requirement while attempting to strike an appropriate balance between the safety of employees and the public and individual privacy concerns. Thus, for example, the direct observation collection of urine specimens will require the use of a same-gender observer.

Employers subject to the DOT’s new direct observation requirements for return to duty and follow-up testing should consult with their collection facilities regarding these requirements. In addition, employers should consider how best to notify the employees in their work force who potentially will be subject to this requirement. That way, if and when a direct observation test arises down the road, the employee in question will not be shocked or surprised by the requirement.